Careers Media center Contacts
DANOFLOX
DANOFLOX

danofloxacin | QJ01MA92

Solution for injection

Treatment of the cattle suffering from acute mastitis (caused by E. coli), as well as of respiratory and digestive tract diseases, caused by organisms susceptible to danofloxacin.

DANOFLOX-M
DANOFLOX-M

danofloxacin

Solution for injection

Treatment of pig diseases of the respiratory system and digestive tract caused by microorganisms sensitive to danofloxacin

Dia DOG & cat
Dia DOG & cat

Chewable tablets

To eliminate acute disorders of intestinal absorption (diarrhea) and promote the withdrawal of the trichobezoar from the digestive canal in cats and dogs.

DIFLUZOL
DIFLUZOL

fluconazole | J02AC01

Capsules

Cryptococcosis, including cryptococcal meningitis and infections of other localizations (e.g., lungs, skin). Treatment of patients HIV carriers and AIDS patients, patients after organ transplantation and other patients who receive therapy with immunosuppressants. 
Fluconazole may be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in patients with AIDS. 
Generalized candidiasis, including candidaemia, disseminated candidiasis, and other forms of invasive candida infection (lesion of abdominal cavity, endocardium, eyes, respiratory and urinary tract). Treatment of patients with malignant neoplasms who are in the ICU and receiving cytostatic and immunosuppressive therapy or are influenced by other factors, which makes them more prone to developing candidiasis. Mucous membrane candidiasis: lesions of the oropharynx, esophagus, non-invasive bronchopulmonary infection, candiduria, mucocutaneous and chronic atrophic candidiasis (candidiasis, caused by denture). Treatment of HIV carriers and AIDS patients. To prevent recurrence of oropharyngeal candidiasis in patients with AIDS.
Genital candidiasis, including vaginal candidiasis, acute or recurrent, and candidal balanitis. Prophylactic use to reduce the frequency of recurrent vaginal candidiasis (3 or more recurrences per year).
Prevention of fungal infections in patients with malignancy who are predisposed to such infections due to chemotherapy or radiation therapy.
Ringworm – athlete's foot, athlete's smooth skin, inguinal ringworm, tinea versicolor, ringworm of the nails (onychomycosis) and dermal Candida infections.
Deep endemic mycoses in patients with an intact immune system, coccidioidomycosis, paracoccidioides, sporotrichosis and histoplasmosis. 

DIFLUZOL
DIFLUZOL

fluconazole | J02AC01

Capsules

Vaginal candidiasis in patients who were previously diagnosed with (or appear sporadically) doctor.

DIFLUZOL
DIFLUZOL

fluconazole | J02A C01

Solution for injection

Cryptococcosis, including cryptococcal meningitis and infections of other localizations (such as lung, skin).  Treatment of AIDS patients and carriers, and patients after organs transplantation and other patients who treated with immunodepressants. Fluconazole can be administered as supportive treatment for a prophylactic of cryptococcal recurrences and AIDS patients. Generalized candidiasis, including candidemia, disseminated candidiasis and other forms of invasive candidasis infections (lesions of abdominal cavity, endocardial lesions, lesions of the eye, respiratory and urinary tract lesions). Treatment of patients with malignant neoplasms, which are located in intensive care unit and treated with cytostatic and immunosuppressive therapy or are impacted by other factors that make them more liable to candidiasis development. Candidiasis of mucous membranes: oropharynx lesions, esophagus, non-invasive bronchopulmonary infection,  candiduria, mucocutaneous and chronic atrophic candidiasis (candidiasis caused by dental prosthesis). Treatment of carriers and AIDS patients. Prevention of recurrence of oropharyngeal candidiasis in AIDS patients. Genital candidiasis, including vaginal candidiasis, acute or recurrent, and candidal balanitis. Prophylactic administration to decrease the frequency of recurrence of vaginal candidiasis (3 or more recurrences per year). Prevention of fungal infections with malignant tumors in patients that are inclined to such infections that are a result of chemotherapy or radiation therapy. Dermatomycosis – foot mycosis, glabrous skin mycosis, ringworm of the groin, pityriasis versicolor, ringworm of the nails, cutaneous candida infections. Deep endemic mycoses - in patients with unaffected immune systems, coccidomycosis, paracoccidiomikoz, sporotrichosis and histoplasmosis.

DIFLUZOL
DIFLUZOL

fluconazole | J02AC01

Capsules

Acute vaginal candidiasis, when local therapy is not appropriate. Balanitis Candida, when local therapy is not appropriate.

DIMARYL
DIMARYL

glimepiride | A10B B12

Tablets

Non-insulin diabetes type II, if sugar level of the blood cannot be maintained only by diet, exercise and weight reduction


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form